Cancer and Diagnostics

Cancer Immunology and Immunotherapy

Researchers are encouraged to submit abstracts for the "Cancer Immunology and Immunotherapy" track at the "World Cancer 2024" conference, focusing on the latest advancements in harnessing the immune system to combat cancer. Abstracts should highlight innovative immunotherapeutic strategies, mechanisms of immune evasion, and biomarkers predictive of treatment response.

Attendees can expect presentations on cutting-edge immunotherapy approaches, including immune checkpoint inhibitors, adoptive cell therapy, cancer vaccines, and cytokine therapies, as well as discussions on combination strategies and overcoming resistance mechanisms. The track will also feature sessions on tumor immunology, including the tumor microenvironment, immune cell subsets, and immune evasion mechanisms exploited by cancer cells.

Additionally, discussions will cover the integration of immunotherapy into standard cancer treatment paradigms, including patient selection, biomarker-driven approaches, and management of immune-related adverse events. Attendees will have the opportunity to engage with leading experts, share insights, and explore collaborative opportunities at the forefront of cancer immunology and immunotherapy research.